Table 1.
Working group | Leaders | Reference(s) |
---|---|---|
High-grade glioma | Patrick Wen | 2 |
Low-grade glioma | Martin Van den Bent | 3 |
Phase 2 design | Eva Galanis | 6 |
Endpoints | David Reardon | 5 |
Surgical trials | Michael Vogelbaum | 4 |
Brain metastases | Nancy Lin | 8–10 |
Leptomeningeal disease | Marc Chamberlain | 11 |
Pediatrics | Mark Kieran | 7 |
Meningioma | Michael Vogelbaum | 12,13 |
Neurological assessment | David Reardon | |
PET | Joerg Tonn | |
Seizures | Edward Avila | |
Steroids | Patrick Wen | |
Immunotherapy | Hideho Okada, David Reardon | 14 |
Spinal tumors | Arjun Sagal | 15 |